Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    HYPOTRICHOSIS 6
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia
Conditions: Alopecia;   Androgenetic Alopecia
Intervention: Drug: Dutasteride 0.5mg oral tablets
2 Unknown  Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: PRGF-Endoret;   Other: Saline Solution

Study has passed its completion date and status has not been verified in more than two years.